Harvard University’s tax-exempt status has been questioned by the Trump Administration—with Harvard responding that there is no legal basis for a revocation. The Administration’s action...
Many states are implementing energy benchmarking programs to track and identify energy use in buildings. These programs aim to encourage energy efficiency and reduce greenhouse gas emissions. Check out...
When engaging in M&A discussions, parties should prioritize rigorous confidentiality measures to protect sensitive business information. Our new confidentiality agreement playbook offers valuable insights...
This practice note discusses Institutional Review Boards (IRBs) within the United States, including their purpose, history, and regulatory framework. The note is a valuable resource for advising life sciences...
Do you need guidance on tipped employee requirements under the Fair Labor Standards Act (FLSA)? Read our newly published checklist, Tipped Employees Checklist (FLSA) , for helpful information. Read now...
FTC Chair Lina Khan told a conference of the American Medical Association on February 14, 2024, that the healthcare market is under the microscope in the Commission’s push for greater competition across the economy. Recent efforts by the FTC in this space include requesting public comment on how powerful “middlemen” in the generic drug market may contribute to shortages of these drugs. The agency also announced a March 5 virtual workshop to examine the role of private equity’s investment in healthcare markets. Additionally, the FTC issued a recent comment supporting the government’s right to “march in” to invalidate a patent if the patent holder is charging an excessive price on a patented drug developed with taxpayer-funded research.
The Antitrust Agency Developments Tracker covers these developments and other FTC and DOJ non-case-related efforts, policy statements, and goings-on at the agencies.
READ NOW »
Related Content
Practical Guidance Updates Featuring the latest updates from your Practical Guidance account.
PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.Experience Lexis+